Work

Publisher Correction: Targeting PD-L2–RGMb overcomes microbiome-related immunotherapy resistance

Year: 2023

Type: erratum

Source: Nature

DOI: 10.1038/s41586-023-06237-8

Authors: Joon Seok Park, Francesca S. Gazzaniga, Meng Wu, Amalia K. Luthens, Jacob Gillis, Wen Zheng, Martin W. LaFleur, Sarah B. Johnson, Golnaz Morad, Elizabeth M. Park, Yifan Zhou, Stephanie S. Watowich, Jennifer A. Wargo, Gordon J. Freeman, Dennis L. Kasper, Arlene H. Sharpe

Institutions: Harvard University, Massachusetts General Hospital, The University of Texas MD Anderson Cancer Center, Dana-Farber Cancer Institute

Language: English

Topic: Cancer Immunotherapy and Biomarkers

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

Funders: National Cancer Institute, National Institute of Allergy and Infectious Diseases

Awards: G4603642344, SPORE in Myeloid Malignancies, T Cell Costimulatory Pathways: Functions and Interactions

OpenAlex ID: W4379015069

Cites:

Cited by: 8

Related to: 10